Current views on the etiology and pathogenesis of ALK-positive anaplastic large cell lymphoma-Reference-Cited by-同舟云学术

Current views on the etiology and pathogenesis of ALK-positive anaplastic large cell lymphoma

Published:2024-04-08 Issue:1 Volume:23 Page:180-191
ISSN:2414-9314
Container-title:Pediatric Hematology/Oncology and Immunopathology
language:
Short-container-title:Voprosy gematologii/onkologii i immunopatologii v pediatrii

Author:

Abramov D. S.¹^ORCID,Fedorova A. S.¹^ORCID,Volchkov E. V.²^ORCID,Myakova N. V.¹^ORCID,Konovalov D. M.³^ORCID

Affiliation:

1. The Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthсare of the Russian Federation

2. The Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthсare of the Russian Federation; Research Institute of Molecular and Cellular Medicine of the Patrice Lumumba Рeoples’ Friendship University of Russia

3. The Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthсare of the Russian Federation; Russian Medical Academy of Continuous Professional Education of Ministry of Healthcare of the Russian Federation

Abstract

ALK-positive anaplastic large cell lymphoma is a mature T-cell lymphoma characterized by translocations that involve the ALK receptor tyrosine kinase coding gene. This illness is known to almost exclusively affect children and young adults. The biology of ALK-positive anaplastic large cell lymphoma is fairly well researched today, with recent studies focusing on the histogenesis of this neoplasm. In this review, we analyze the existing world literature data on the etiology and pathogenesis of this disease.

Publisher

Fund Doctors, Innovations, Science for Children

Reference79 articles.

1. Lowe E.J., Gross T.G. Anaplastic large cell lymphoma in children and adolescents. Pediatr Hematol Oncol 2013; 30 (6): 509–19. DOI: 10.3109/08880018.2013.805347

2. Stein H., Foss H.D., Durkop H., Marafioti T., Delsol G., Pulford K., et al. CD30+ anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features. Blood 2000; 96 (12): 3681–95. DOI: 10.1182/BLOOD.V96.12.3681

3. Falini B., Lamant L., Campo E., Jaffe E.S., Gascoyne R.D., Stein H., et al. Anaplastic large cell lymphoma, ALK positive. In: Swerdlow S.H., Campo E., Harris N.L., Jaffe E.S., Pileri S.A., Stein H. (eds.). Who Classification of Tumors of Hematopoietic and Lymphoid Tissues. IARC: Lyon (France); 2017. Рp. 413–418.

4. Benharroch D., Meguerian-Bedoyan Z., Lamant L., Amin C., Brugières L., Terrier-Lacombe M.J., et al. ALK-positive lymphoma: A single disease with a broad spectrum of morphology. Blood 1998; 91 (6): 2076–84. URL: https://www.researchgate.net/publication/13740376_ALK-Positive_Lymphoma_A_Single_Disease_With_a_Broad_Spectrum_of_Morphology

5. Lamant L., McCarthy K., D’Amore E., Klapper W., Nakagawa A., Fraga M., et al. Prognostic impact of morphologic and phenotypic features of childhood ALK-positive anaplastic large-cell lymphoma: results of the ALCL99 study. J Clin Oncol 2011; 29 (35): 4669–76. DOI: 10.1200/JCO.2011.36.5411